Evaluation of Hepatitis B Reactivation Among 62,920 Veterans Treated with Oral Hepatitis C Antivirals

Overview

Journal Hepatology

Specialty Gastroenterology

Date 2017 Feb 28

PMID 28240789

Citations 47

Authors

Pamela S Belperio

Troy A Shahoumian

Larry A Mole

Lisa I Backus

Affiliations

Soon will be listed here.

Abstract

Conclusion: HBV reactivation of varying severity, even in the setting of isolated hepatitis B core antibody, with or without accompanying hepatitis can occur-though the occurrence of accompanying severe hepatitis was rare. (Hepatology 2017;66:27-36).

Citing Articles

SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024.

Alghamdi A, Alghamdi H, Alserehi H, Babatin M, Alswat K, Alghamdi M Saudi J Gastroenterol. 2024; 30(Supp 1):S1-S42.

PMID: 38167232 PMC: 10856511. DOI: 10.4103/sjg.sjg_333_23.

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023.

Conners E, Panagiotakopoulos L, Hofmeister M, Spradling P, Hagan L, Harris A MMWR Recomm Rep. 2023; 72(1):1-25.

PMID: 36893044 PMC: 9997714. DOI: 10.15585/mmwr.rr7201a1.

Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis.

Oh J, Park D, Ko M, Yoo J, Yim S, Ahn J J Pers Med. 2022; 12(12).

PMID: 36556178 PMC: 9781230. DOI: 10.3390/jpm12121957.

Hepatitis B Reactivation Following Eradication of HCV with Direct-Acting Antiviral Drugs (DAAs) in a Cohort of Patients from Different Institutions in Egypt.

Abdelbary M, Samir R, El-Nahaas S, Shahin R, El-Sayed M, Gaber Y J Clin Exp Hepatol. 2022; 12(5):1276-1284.

PMID: 36157140 PMC: 9499996. DOI: 10.1016/j.jceh.2022.04.020.

Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.

Ibrahim Salama I, Raslan H, Abdel-Latif G, Salama S, Sami S, Shaaban F World J Hepatol. 2022; 14(6):1053-1073.

PMID: 35978668 PMC: 9258264. DOI: 10.4254/wjh.v14.i6.1053.